Osteosarcoma is the most common bone cancer in dogs, and it hides a hard truth: even when the visible tumor is removed, microscopic cancer has almost always already spread. This guide explains what that means for treatment, what standard care costs, the survival numbers families deserve to know, and the trials working to break the ceiling in 2026.
By Brycen Levings | Editor: Tariq Shah
October 28, 2026
Read more →Apocrine gland anal sac adenocarcinoma is an aggressive tumor that often spreads to lymph nodes early and can send calcium levels dangerously high. But with surgery and modern multimodal care, many dogs live well beyond two years. This guide explains the disease, its costs, and the clinical trials expanding options in 2026.
By Brycen Levings | Editor: Tariq Shah
September 21, 2026
Read more →Histiocytic sarcoma is an aggressive cancer of the immune system with a strong breed signature — Bernese Mountain Dogs, Flat-Coated Retrievers, Rottweilers, and Golden Retrievers are especially at risk. This guide explains the localized and disseminated forms, what treatment costs, and the clinical trials expanding options in 2026.
By Brycen Levings | Editor: Tariq Shah
August 26, 2026
Read more →Transitional cell carcinoma is the most common cancer of the canine urinary tract, and it usually develops in the worst possible spot for surgery. But it's also well understood at the molecular level, giving vets strong diagnostic insight into the disease and a growing list of targeted trial options. Here's what to know in 2026.
By Brycen Levings | Editor: Tariq Shah
August 14, 2026
Read more →"Soft tissue sarcoma" is an umbrella term for a family of connective-tissue tumors that tend to grow locally rather than spread — which makes complete surgery the central challenge and grade the central predictor. This guide explains the tumor types, what treatment costs, and the clinical trials improving local control in 2026.
By Brycen Levings | Editor: Tariq Shah
August 7, 2026
Read more →Melanoma in dogs is a tale of two diseases — often harmless on the skin, but one of the most aggressive cancers a dog can face in the mouth or on a toe. It's also home to veterinary medicine's first licensed cancer vaccine. This guide explains the forms, the treatments, the costs, and the clinical trials making it a hopeful area in 2026.
By Brycen Levings | Editor: Tariq Shah
July 30, 2026
Read more →Cancer changes how dogs metabolize protein, fat, and carbohydrate — and often kills their appetite. Here's what to feed a dog with cancer, and how to get them eating.
By Tariq Shah | Editor: Brycen Levings
July 23, 2026
Read more →Few diagnoses land as hard as hemangiosarcoma — an aggressive cancer of the blood-vessel lining that often announces itself with a sudden collapse. This guide gives families the honest survival picture, explains what standard treatment realistically offers, and covers the clinical trials working to change the numbers in 2026.
By Brycen Levings | Editor: Tariq Shah
July 16, 2026
Read more →Mast cell tumors are the most common skin cancer in dogs — and the most unpredictable, ranging from harmless lumps to aggressive cancers that spread to internal organs. This guide explains how grade drives everything, what standard treatment costs, and the clinical trials giving dogs new options in 2026.
By Brycen Levings | Editor: Tariq Shah
July 8, 2026
Read more →Lymphoma accounts for roughly 20% of all canine cancers, making it the single most frequently diagnosed malignancy in dogs. The good news is that lymphoma is also one of the more actively researched canine cancers, with 20 active clinical trials currently open through Pet Trial Finder across 25 accredited U.S. veterinary universities. This guide walks through what canine lymphoma is, what standard treatment looks like and what it costs, and how clinical trials are expanding the options available to dogs and their families in 2026.
By Brycen Levings | Editor: Tariq Shah
May 29, 2026
Read more →For over a century, oncologists have relied on chemotherapy to treat cancer. These drugs target rapidly dividing cells such as cancer cells and, unfortunately, healthy hair follicles—disrupting their replication process to destroy them. If a high enough dose or the right combination of drugs is administered, it is theoretically possible to eradicate all tumor cells.
By Tariq Shah
May 21, 2026
Read more →A cancer diagnosis in your dog doesn't have to mean your only options are standard chemotherapy or surgery. Veterinary clinical trials at accredited U.S. universities are actively recruiting dogs with cancer right now — many offering cutting-edge treatments at little or no cost. Here's everything you need to know about how trials work, which cancers have the most active research, and how to find out if your dog qualifies.
By Brycen Levings | Editor: Tariq Shah
May 11, 2026
Read more →Veterinary clinical trials give dogs and cats with cancer access to cutting-edge treatments — often fully funded by the research institution. Most pet owners don't know these trials exist, or that their pet may qualify. This guide explains exactly what they are, how they work, and how to find out if your pet is eligible.
By Brycen Levings | Editor: Tariq Shah
May 4, 2026
Read more →Connect with leading veterinary oncology research programs offering innovative cancer treatments
Get Started